Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
David Longo
CEO
dave@ordaos.bio

Message the company or request a 1:1 meeting here

Ordaos founded with a revolutionary idea: drug discovery doesn’t have to rely on serendipity or be strangled by currently known science. We formed Ordaos to custom design mini-proteins (50-200aa), previously only imagined, and accelerate the drug discovery and development process. Recent AI breakthroughs such as enhanced natural language algorithms, distributed cloud computational power and a generative learning engine enable Ordaos to go beyond small molecule design to rapidly design, test, and optimize novel therapeutic proteins, all in silico, and maximize the speed and the probability of success in subsequent clinical development phases. Through these innovations, we deliver an early drug discovery cycle that takes minutes, not months.